Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Avista Healthcare Partners acquired Bentec Medical from Greyrock Capital Group and Hermitage Equity Partners to strengthen its medical device manufacturing presence. Bentec, founded in 1994 and headquartered in Woodland, California, specializes in complex silicone components for medical device OEMs and a portfolio of proprietary medical devices used by healthcare providers.
Bentec’s products serve ENT, oncology, aesthetics, biliary surgery, and neonatal care. Avista plans to support Bentec’s next phase of growth by investing in innovation, expanding manufacturing capacity, expanding geographically, and pursuing potential strategic acquisitions.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026